InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Lloyd-Smith Malcolm, Directeur Réglementaire. Director active across 1 companies, notably Neurocrine Biosciences INC. Cumulatively, 4 filings have been logged. Total volume traded: €2.8m. The latest transaction was disclosed on 7 February 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€61,000865 shares@ €70.51970.0004% mcap4.4% of flow
Common Stock
SEC:0001209191-22-008214·
€61,000865 shares@ €70.51970.0004% mcap2.2% of flow
Common Stock
SEC:0001209191-22-008214:0·
€1m16,709 shares@ €79.33760.0093% mcap95.6% of flow
Common Stock
SEC:0001209191-21-048560·
€1m16,709 shares@ €79.33760.0093% mcap47.8% of flow
Common Stock
SEC:0001209191-21-048560:0·
4 of 4 declarations
About Lloyd-Smith Malcolm
Lloyd-Smith Malcolm is the Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC. He is responsible for regulatory compliance and risk management. His role is essential in ensuring that the company adheres to all applicable regulations in the biotechnology sector.
